QIAGEN N.V. (NYSE: QGEN) Investor Investigation Over Possible Violations Of Securities Laws

Investors who purchased shares of QIAGEN N.V. (NYSE: QGEN), have certain options and should contact the Shareholders Foundation, Inc.

To have your information reviewed for options and to recieve notifications about this investigation, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Company Name(s): 
Affected Securities: 

An investigation on behalf of investors of QIAGEN N.V. (NYSE: QGEN) shares over potential securities laws violations by QIAGEN N.V. and certain of its directors and officers in connection with certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of QIAGEN N.V. (NYSE: QGEN) concerning whether a series of statements by QIAGEN N.V. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Netherlands based QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. QIAGEN N.V. reported that its annual Total Revenue rose from over 1.41 billion in 2017 to over 1.5 billion in 2018 and that its Net Income increased from 40.39 million to 190.38 million in 2018.

Shares of QIAGEN N.V. (NYSE: QGEN) grew from $21.05 per share in June 2016 to $41.47 per share in April 2019.

On October 7, 2019, QIAGEN N.V. announced third quarter results would come in below previous estimates and also announced that its CEO has resigned. QIAGEN N.V. announced it estimates third-quarter sales at constant growth exchange rate of 3%, far lower than its previously estimated sales growth of 4% to 5%. Qiagen also announced its long-term CEO, Peer M. Schatz, who served the Company for 27-years, would resign as CEO and Chairman of the Board effective immediately. The Company's Senior Vice President, Thierry Bernard will act as interim CEO while the Company undertakes a search for a new CEO.